Moderna's COVID-19 vaccine could cruise to $5B in sales—or more, analysts say

Moderna's COVID-19 vaccine could cruise to $5B in sales—or more, analysts say

Source: 
Fierce Pharma
snippet: 

Moderna has never scored a commercial approval for any of its drugs or vaccines, but analysts with Jefferies think the company has a winner in its COVID-19 shot. And not just any winner—a multibillion-dollar blockbuster.